Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIOGY | OTC Markets | USD | Delayed | |
BIOGBs | BATS Europe | SEK | Delayed | |
0GTN | London | SEK | Real-time | |
BIOGb | Stockholm | SEK | Real-time |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 297.77 | 317.69 | 315.22 | 365.82 |
Gross Profit | 225.39 | 235.85 | 226.44 | 262.51 |
Operating Income | 89.18 | 119.22 | 86.58 | 145.94 |
Net Income | 67.36 | 101.5 | 80.55 | 115.94 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 2333.19 | 2304.25 | 2157.08 | 2324 |
Total Liabilities | 302.84 | 318.98 | 273.27 | 237.14 |
Total Equity | 2030.34 | 1985.27 | 1883.81 | 2086.87 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 121.78 | 98.98 | 104.55 | 98.43 |
Cash From Investing Activities | -13.91 | -8.92 | -24.55 | -1.33 |
Cash From Financing Activities | -7.63 | -1.7 | -295.74 | -3.36 |
Net Change in Cash | 91.66 | 82.96 | -211.26 | 92.46 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review